These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 8279546

  • 1. Linear V1-vascular vasopressin antagonists suitable for radioiodination, biotinylation, and fluorescent labeling.
    Thibonnier M, Bayer AL, Madhun Z.
    Am J Physiol; 1993 Dec; 265(6 Pt 1):E906-13. PubMed ID: 8279546
    [Abstract] [Full Text] [Related]

  • 2. Cytoplasmic and nuclear signaling pathways of V1-vascular vasopressin receptors.
    Thibonnier M, Bayer AL, Leng Z.
    Regul Pept; 1993 Apr 29; 45(1-2):79-84. PubMed ID: 8511370
    [Abstract] [Full Text] [Related]

  • 3. Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor.
    Thibonnier M, Auzan C, Madhun Z, Wilkins P, Berti-Mattera L, Clauser E.
    J Biol Chem; 1994 Feb 04; 269(5):3304-10. PubMed ID: 8106369
    [Abstract] [Full Text] [Related]

  • 4. A V1-vascular vasopressin antagonist suitable for radioiodination and photoaffinity labeling.
    Thibonnier M, Chehade N, Hinko A.
    Am J Hypertens; 1990 Jun 04; 3(6 Pt 1):471-5. PubMed ID: 2369497
    [Abstract] [Full Text] [Related]

  • 5. Multiple signaling pathways of V1-vascular vasopressin receptors of A7r5 cells.
    Thibonnier M, Bayer AL, Simonson MS, Kester M.
    Endocrinology; 1991 Dec 04; 129(6):2845-56. PubMed ID: 1659517
    [Abstract] [Full Text] [Related]

  • 6. Vasopressin-binding sites in the pig pituitary gland: competition by novel vasopressin antagonists suggests the existence of an unusual receptor subtype in the anterior lobe.
    Arsenijevic Y, Dubois-Dauphin M, Tribollet E, Manning M, Sawyer WH, Dreifuss JJ.
    J Endocrinol; 1994 Jun 04; 141(3):383-91. PubMed ID: 8071638
    [Abstract] [Full Text] [Related]

  • 7. Vasopressin (V1) receptor characteristics in rat aortic smooth muscle cells.
    Gopalakrishnan V, Xu YJ, Sulakhe PV, Triggle CR, McNeill JR.
    Am J Physiol; 1991 Dec 04; 261(6 Pt 2):H1927-36. PubMed ID: 1836312
    [Abstract] [Full Text] [Related]

  • 8. A novel radiolabeled vasopressin antagonist: [3H-Phe]-desGlyd(CH2)5D-Tyr(Et)VAVP, [3H]-SK&F 101926.
    Stassen FL, Heckman G, Schmidt D, Nambi P, Aiyar N, Landvatter S, Crooke ST.
    Mol Pharmacol; 1987 Mar 04; 31(3):267-72. PubMed ID: 2951585
    [Abstract] [Full Text] [Related]

  • 9. Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells.
    Serradeil-Le Gal C, Herbert JM, Delisee C, Schaeffer P, Raufaste D, Garcia C, Dol F, Marty E, Maffrand JP, Le Fur G.
    Am J Physiol; 1995 Jan 04; 268(1 Pt 2):H404-10. PubMed ID: 7840290
    [Abstract] [Full Text] [Related]

  • 10. Effects of amiloride analogues on AVP binding and activation of V1-receptor-expressing cells.
    Thibonnier M, Bayer AL, Simonson MS, Douglas JG.
    Am J Physiol; 1992 Jan 04; 262(1 Pt 1):E76-86. PubMed ID: 1733254
    [Abstract] [Full Text] [Related]

  • 11. Identification and characterization of vascular (V1) vasopressin receptors of an established smooth muscle cell line.
    Stassen FL, Heckman G, Schmidt D, Aiyar N, Nambi P, Crooke ST.
    Mol Pharmacol; 1987 Mar 04; 31(3):259-66. PubMed ID: 2951584
    [Abstract] [Full Text] [Related]

  • 12. Vasopressin increases cytosolic free [Ca2+] in the neonatal rat cardiomyocyte. Evidence for V1 subtype receptors.
    Xu YJ, Gopalakrishnan V.
    Circ Res; 1991 Jul 04; 69(1):239-45. PubMed ID: 2054937
    [Abstract] [Full Text] [Related]

  • 13. Reconstitution of solubilized V1 vasopressin receptors of human platelets.
    Thibonnier M, Bayer AL, Simonson MS, Snajdar RM.
    Am J Physiol; 1990 Nov 04; 259(5 Pt 1):E751-6. PubMed ID: 2146884
    [Abstract] [Full Text] [Related]

  • 14. Fluorescent pseudo-peptide linear vasopressin antagonists: design, synthesis, and applications.
    Durroux T, Peter M, Turcatti G, Chollet A, Balestre MN, Barberis C, Seyer R.
    J Med Chem; 1999 Apr 08; 42(7):1312-9. PubMed ID: 10197974
    [Abstract] [Full Text] [Related]

  • 15. 125I-d(CH2)5[Tyr(Me)2, Tyr(NH2)9]AVP: iodination and binding characteristics of a vasopressin receptor ligand.
    Elands J, Barberis C, Jard S, Lammek B, Manning M, Sawyer WH, de Kloet ER.
    FEBS Lett; 1988 Mar 14; 229(2):251-5. PubMed ID: 2964381
    [Abstract] [Full Text] [Related]

  • 16. G protein coupling of human platelet V1 vascular vasopressin receptors.
    Thibonnier M, Goraya T, Berti-Mattera L.
    Am J Physiol; 1993 May 14; 264(5 Pt 1):C1336-44. PubMed ID: 8498489
    [Abstract] [Full Text] [Related]

  • 17. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M, Cheng LL, Stoev S, Bankowski K, Przybyiski J, Klis WA, Sawyer WH, Wo NC, Chan WY.
    J Pept Sci; 1995 May 14; 1(1):66-79. PubMed ID: 9222985
    [Abstract] [Full Text] [Related]

  • 18. [125I]-[d(CH2)5, Sar7]AVP: a selective radioligand for V1 vasopressin receptors.
    Kelly JM, Abrahams JM, Phillips PA, Mendelsohn FA, Grzonka Z, Johnston CI.
    J Recept Res; 1989 May 14; 9(1):27-41. PubMed ID: 2521670
    [Abstract] [Full Text] [Related]

  • 19. Arginine vasopressin inhibits interleukin-1 beta-stimulated nitric oxide and cyclic guanosine monophosphate production via the V1 receptor in cultured rat vascular smooth muscle cells.
    Kusano E, Tian S, Umino T, Tetsuka T, Ando Y, Asano Y.
    J Hypertens; 1997 Jun 14; 15(6):627-32. PubMed ID: 9218182
    [Abstract] [Full Text] [Related]

  • 20. Novel linear antagonists of the antidiuretic (V2) and vasopressor (V1) responses to vasopressin.
    Manning M, Klis WA, Kruszynski M, Przybylski JP, Olma A, Wo NC, Pelton GH, Sawyer WH.
    Int J Pept Protein Res; 1988 Dec 14; 32(6):455-67. PubMed ID: 3246475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.